Stammdaten
MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog to treat anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland.
Unternehmen & Branche
| Name | MIRA PHARMACEUTICALS, INC. |
|---|---|
| Ticker | MIRA |
| CIK | 0001904286 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Drug Manufacturers - General |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 42,7 Mio. USD |
| Beta | 1,94 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | -10,442,485 | -1.35 | 11,093,605 | 10,391,537 | |
| 2025-09-30 | 10-Q | -1,137,673 | -1.18 | 7,633,280 | 7,549,354 | |
| 2025-06-30 | 10-Q | -1,537,712 | -0.09 | 868,318 | 569,859 | |
| 2025-03-31 | 10-Q | -1,783,779 | -0.11 | 1,400,338 | 1,294,165 | |
| 2024-12-31 | 10-K | -7,852,659 | -0.51 | 2,923,099 | 2,199,750 | |
| 2024-09-30 | 10-Q | -2,043,867 | -0.14 | 4,266,571 | 3,573,737 | |
| 2024-06-30 | 10-Q | -1,691,325 | -0.11 | 3,015,578 | 2,218,966 | |
| 2024-03-31 | 10-Q | -1,717,771 | -0.15 | 3,808,791 | 3,156,785 | |
| 2023-12-31 | 10-K | -11,982,343 | -0.85 | 4,932,443 | 4,374,346 | |
| 2023-09-30 | 10-Q | -3,587,816 | -0.26 | 9,018,212 | 8,115,311 | |
| 2023-06-30 | 10-Q | -1,266,107 | -0.10 | 3,825,136 | 1,196,619 | |
| 2023-03-31 | 10-Q | -1,341,044 | -0.10 | |||
| 2022-12-31 | 10-K | -7,058,190 | -0.40 | 858,074 | -596,232 | |
| 2022-09-30 | 10-Q | -1,810,684 | -0.14 | |||
| 2022-06-30 | 10-Q | -2,422,979 | -0.19 | |||
| 2022-03-31 | 10-Q | -1,475,046 |
Fondsaktivität (Vorquartalsvergleich)
Insider-Transaktionen (12 Monate)
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.